<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap13" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>13</ChapterID>
            <ChapterNumber>13</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_13</ChapterDOI>
            <ChapterSequenceNumber>13</ChapterSequenceNumber>
            <ChapterTitle Language="En">A Rat Middle Cerebral Artery Occlusion Model and Intravenous Cellular Delivery</ChapterTitle>
            <ChapterFirstPage>187</ChapterFirstPage>
            <ChapterLastPage>195</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_13">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Masanori</GivenName>
                  <FamilyName>Sasaki</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_13">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Osamu</GivenName>
                  <FamilyName>Honmou</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_13" CorrespondingAffiliationID="Aff1_13">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeffery</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Kocsis</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>jeffery.kocsis@yale.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_13">
                <OrgDivision>Department of Neurology and Center for Neuroscience and Regeneration Research</OrgDivision>
                <OrgName>Yale University School of Medicine, VA Connecticut Healthcare System</OrgName>
                <OrgAddress>
                  <Street>333 Cedar Street</Street>
                  <City>New Haven</City>
                  <State>CT</State>
                  <Postcode>06510</Postcode>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_13" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>A useful experimental model to study the pathophysiology of cerebral ischemia without craniectomy is the middle cerebral artery occlusion (MCAO) model. In this model, an intraluminal suture is advanced from the internal carotid artery to occlude the base of the MCA. Standardized procedures in terms of suture size, animal weight, and the details of intraluminal suture insertion are well established. This procedure can produce reversible occlusion after insertion of the intraluminal suture for a specified period of time, or a permanent occlusion by leaving the suture in place. This model has been useful in the study of both the normal pathophysiology of cerebral ischemia and in assessing interventional therapeutic approaches for stroke therapy. One approach has been the intravenous delivery of bone marrow-derived mescenchymal stem cells at various times after MCAO. Histological and magnetic resonance imaging have been used to quantify infarction volume in this model system.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words:</Heading>
              <Keyword>Middle cerebral artery occlusion</Keyword>
              <Keyword>Stroke</Keyword>
              <Keyword>TTC</Keyword>
              <Keyword>Transplantation</Keyword>
              <Keyword>Intravenous</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_13">
              <Heading>Introduction</Heading>
              <Para>There are several model systems in rodent to induce reductions in global cerebral blood flow including multiple vessel occlusion and hypotension (<CitationRef CitationID="CR1_13">1</CitationRef>, <CitationRef CitationID="CR2_13">2</CitationRef>). Longa et al. (<CitationRef CitationID="CR3_13">3</CitationRef>) developed a much less invasive stroke model for either temporary or permanent regional ischemia, which is now commonly utilized in cerebral ischemia experiments in rodents. This model has allowed a number of advances in better understanding the pathophysiology of stroke (<CitationRef CitationID="CR4_13">4</CitationRef>–<CitationRef CitationID="CR6_13">6</CitationRef>) and in preclinical work showing efficacy of interventional approaches that reduce lesion volume and improve functional outcome. These approaches include pharmacological (<CitationRef CitationID="CR7_13">7</CitationRef>, <CitationRef CitationID="CR8_13">8</CitationRef>) and cell-based (<CitationRef CitationID="CR9_13">9</CitationRef>–<CitationRef CitationID="CR13_13">13</CitationRef>) interventional strategies.</Para>
              <Para>Transplantation of mesenchymal stem cells (MSC) after cerebral ischemia in the middle cerebral artery occlusion (MCAO) model has been reported to reduce infarction size and ameliorate functional deficits in rodent cerebral ischemia models (<CitationRef CitationID="CR11_13">11</CitationRef>, <CitationRef CitationID="CR13_13">13</CitationRef>, <CitationRef CitationID="CR14_13">14</CitationRef>). In addition, gene-modified human mesenchymal stem cells (hMSC) have greater therapeutic benefits on stroke following transplantation (<CitationRef CitationID="CR15_13">15</CitationRef>, <CitationRef CitationID="CR16_13">16</CitationRef>). The release of trophic factors from transplanted MSCs may contribute to the reduction in infarction size and to the recovery of function following ischemia in recipient animals (<CitationRef CitationID="CR10_13">10</CitationRef>–<CitationRef CitationID="CR14_13">14</CitationRef>, <CitationRef CitationID="CR17_13">17</CitationRef>–<CitationRef CitationID="CR20_13">20</CitationRef>). Several hypotheses to account for these therapeutic effects have been suggested, and current thinking is that neuroprotective and neovascularization, rather than neurogenesis are responsible for the early therapeutic effects. In this chapter, we describe a protocol for intraluminal suture induction of MCAO, an intravenous delivery method for cells and the use of <Emphasis Type="Bold">2,3,5</Emphasis>-triphenyltetrazolium chloride (TTC) staining and magnetic resonance imaging (MRI) for assessing lesion volume in the MCAO model.</Para>
            </Section1>
            <Section1 ID="Sec2_13">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_13">
                <Heading>Induction of the
Middle Cerebral Artery
Occlusion in the Rat</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Animals: Male Sprague–Dawley rats (250–300 g)</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Anesthesia: Ketamine (75 mg/kg) and xylazine (10 mg/kg)</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Surgical tools: Surgical Blade (#10, Becton Dickinson, NJ, USA), Dumont forceps (#5, Fine Science Tools, CA, USA), Scissor, (Cohan-Vannas, Fine Science Tools, CA, USA), Scissor, (Fine Iris Scissor, Fine Science Tools, CA, USA), ­Retractor, (Agricola, Fine Science Tools, CA, USA), Needle holder, (Olsen-Hegar, Fine Science Tools, CA, USA), Bipolar coagulation unit (MACAN, IL, USA), Micro clamp (Micro Serrefine, Fine Science Tools, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Surgical supplies: Cotton Pellets (Richmond Dental, NC, USA), Gauze Sponges (Tyco Healthcare, MA, USA), Suture (4-0 Nylon monofilament, Sharpoint and Look, PA, USA), Surgical scrub: Betadine and 70% (v/v) ethanol, 0.9% (w/v) saline, sterile.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Filament for MCA occlusion: 3-0 surgical suture (Dermalon, Sherwood Davis and Geck, UK).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Surgical/Dissecting Microscope (10–50×).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Vital Signs parameters: Rectal temperature monitor (e.g., 43TD; Yellow Springs Instruments, Yellow Springs, OH), Thermal blanket (e.g., GAYMAR, NY, USA), Heart rate monitor (e.g., NPB-40; Nellcor, Pleasanton, CA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Physiological monitoring system: PE-50 (Becton Dickinson, NJ, USA), Heart rate and blood pressure monitor system (e.g., Spike2, CED, UK).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec4_13">
                <Heading>Intravenous
Delivery of the
Transplanted Cells</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Anesthesia, Surgical tools (same as in <Emphasis Type="Bold">Subheading</Emphasis>
                          <InternalRef RefID="Sec3_13">2.1</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>PE-10 (Becton Dickinson, NJ, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>1-ml Syringe (Becton Dickinson, NJ, USA).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec5_13">
                <Heading>TTC Staining
and Quantitative
Analysis of Infarct
Volume</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>2% solution of 2,3,5-triphenyltetrazolium chloride (TTC) in normal saline, (Sigma, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Sodium pentobarbital (50 mg/kg).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Microtome (Microslicer DTK-3000, Dosaka, Japan) or equivalent such as a Vibratome.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>NIH image software (MD, USA).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec6_13">
                <Heading>MRI</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>7-T, 18-cm-bore superconducting magnet (Oxford Magnet Technologies).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>UNITYINOVA console (Oxford Instruments, Oxford, UK; and Varian, Inc., Palo Alto, CA).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec7_13">
              <Heading>Methods</Heading>
              <Para>The overall objective is to induce focal cerebral infarction in a defined hemisphere in brain in order to study biochemical changes following stroke and to assess therapeutic interventions. The basic approach is to insert a monofilament (nylon suture) through the external carotid artery (ECA) and then into the common carotid where the filament is fed into internal carotid artery (ICA) until it blocks the middle cerebral artery (MCA). The filament can then be left in place for a designated period of time followed by removal of the filament, or the filament can be cut and left in place for a permanent MCA occlusion. The rats can then be studied at various postsurgery recovery times after lesion induction. Moreover, interventional approaches such as intravenous infusion of MSCs can be carried out at defined postinfarction times. The duration of MCA occlusion, the time of experimental intervention (cell, drug delivery, etc.), and survival times can be altered to suit individual experimental designs.</Para>
              <Para>Assessment of infarction volume is an important outcome measure as are more refined histological and behavioral analyses. Here we describe two basic approaches to assess gross lesion volume: TTC staining of brain and in vivo MRI. Other measures such as cerebral blood flow, behavioral analyses, and detailed immunohistochemical studies can be found in the papers cited in <Emphasis Type="Bold">Subheading</Emphasis>
                <InternalRef RefID="Sec1_13">1</InternalRef>. A critical element in the MCAO model is consistency in lesion volume between animals. Selecting animals of similar weight and gender and standardizing surgical procedures are important to achieve lesion consistency. Additionally ­monitoring temperature, blood pH, PO<Subscript>2</Subscript>, and PCO<Subscript>2</Subscript> throughout the surgery will allow selection of animals with a similar physiological response to the procedure.</Para>
              <Section2 ID="Sec8_13">
                <Heading>Induction of the
Middle Cerebral Artery
Occlusion in the Rat</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Male Sprague–Dawley rats weighing 250–300 g are anesthetized by intraperitoneal (i.p.) injection of a mixture of ketamine (75 mg/kg) and xylazine (10 mg/kg).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Rectal temperature is monitored and body temperature is maintained at 37°C with an infrared heat lamp and standard heating pad. The area over the throat and the inner thigh are shaved and scrubbed with betadine.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>To monitor blood pH, PO<Subscript>2</Subscript>, and PCO<Subscript>2</Subscript> with a heart rate and blood pressure monitor system throughout the surgery, the left femoral artery is cannulated with a PE-50 for measuring.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>The right common carotid artery (CCA) is exposed by first making a midline incision through the skin over the ventral neck muscles. A retractor is positioned to reflect the digastric and sternomastoid muscles, and the omohyoid muscle is separated. The occipital artery branches of the ECA are then isolated and coagulated. See <Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig1">1</InternalRef> for schematic of arterial system.<Figure Category="Standard" Float="Yes" ID="Fig1">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 1</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Schematic showing suture insertion into the external carotid artery. <Emphasis Type="Italic">ACA</Emphasis> Anterior cerebral artery, <Emphasis Type="Italic">OC</Emphasis> Optic chiasm, <Emphasis Type="Italic">MCA</Emphasis> Middle cerebral artery, <Emphasis Type="Italic">PCA</Emphasis> Posterior cerebral artery, <Emphasis Type="Italic">SCA</Emphasis> Superior cerebellar artery, <Emphasis Type="Italic">Pcom</Emphasis> Posterior communicating artery, <Emphasis Type="Italic">PPA</Emphasis> Pterygopalatine artery, <Emphasis Type="Italic">BA</Emphasis> Basilar artery, <Emphasis Type="Italic">VA</Emphasis> Vertebral artery, <Emphasis Type="Italic">ST</Emphasis> Superior thyroid artery, <Emphasis Type="Italic">OA</Emphasis> Occipital artery, <Emphasis Type="Italic">ECA</Emphasis> External carotid artery, <Emphasis Type="Italic">ICA</Emphasis> Internal carotid artery, <Emphasis Type="Italic">CCA</Emphasis> Common carotid artery</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_13_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="LinedrawHalftone"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Next, the superior thyroid and ascending pharyngeal arteries are blunt dissected and coagulated. The ECA is dissected further distally and coagulated along with the terminal lingual and maxillary artery branches. The ICA is isolated and carefully separated from the adjacent vagus nerve by blunt dissection. Further dissection will identify the ansa of the glossopharyngeal nerve at the origin of the pteryopalatine artery. This artery is a posteriorly directed extracranial branch of the ICA and is ligated with 7-0 nylon suture close to its origin. After this dissection and occlusion of arterial branches, the ICA is the only remaining intact extracranial branch of the CCA.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>A 6-0 suture is then placed loosely around the ECA stump, and a curved microvascular clip is used to occlude circulation of the CCA and ICA by clamping at the junction where they meet the ECA stump.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>A 5.0-cm length of 3-0 surgical suture (Dermalon, Sherwood Davis and Geck, UK) with the tip rounded by heating near a flame is advanced from the ECA into the lumen of the ICA until it blocks the origin of the MCA (20.0–22.0 mm of advancement) (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_13">1</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>At a specified time after MCAO (usually 45–60 min), reperfusion is performed by withdrawal of the suture until the tip cleared the ICA (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_13">2</InternalRef>). The suture can be left in place for permanent occlusion.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>The incision is closed.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec9_13">
                <Heading>Intravenous
Delivery of the
Transplanted Cells
Such as Mesenchymal
Stem Cells</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Cell suspension is prepared.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Rats are anesthetized with ketamine (75 mg/kg) and xylazine (10 mg/kg) i.p.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>The left femoral vein is carefully exposed with dissecting microscope under sterile technique and cannulated using PE-10 tube connected to a 1-ml syringe. Injections of cells or control media can be directly delivered. This cannulation method assures that all of the cell suspension is injected.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>The incision is closed.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec10_13">
                <Heading>TTC Staining and Quantitative Analysis of Infarct Volume (<Emphasis Type="BoldItalic">Fig.</Emphasis>
                  <InternalRef RefID="Fig2">2</InternalRef>)</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>At any specified time after MCAO induction, the rats are deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.).<Figure Category="Standard" Float="Yes" ID="Fig2">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 2</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Brain slices stained with 2,3,5-triphenyltetrazolium chloride (TTC) to visualize infarcted brain. TTC-stained brain slices from rats that were intravenously transplanted control media (<Emphasis Type="Bold">a</Emphasis>) and with autologous bone marrow cells at 6 h after MCAO (<Emphasis Type="Bold">b</Emphasis>). Note the larger infarction area particularly in basal ganglia nuclei in (<Emphasis Type="Bold">a</Emphasis>). Scale bar corresponds to 1.0 mm (modified from Iihoshi et al. (<CitationRef CitationID="CR11_13">11</CitationRef>))</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_13_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>The brains are removed carefully and cut into coronal 1-mm sections using a tissue chopper or a Vibratome.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>The fresh brain slices are immersed in a 2% solution of 2,3,5-triphenyltetrazolium chloride (TTC) in normal saline at 37°C for 30 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>The cross-sectional area of infarction in each brain slice is examined and photographed with a dissection microscope and is measured using an image analysis software, NIH image.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>The infarcted area appears white and normal brain red (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig2">2</InternalRef>).The total infarct volume for each brain is calculated by summation of the infarcted area of all brain slices.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec11_13">
                <Heading>MRI (<Emphasis Type="BoldItalic">Fig.</Emphasis>
                  <InternalRef RefID="Fig3">3</InternalRef>)</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Rats are anesthetized with ketamine (75 mg/kg) and xylazine (10 mg/kg) i.p.<Figure Category="Standard" Float="Yes" ID="Fig3">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 3</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>DWI- and T<Subscript>2</Subscript>-weighted images (T<Subscript>2</Subscript>), collected at 3 h (column 1), 3 days (column 2), and 7 days (column 3) postlesion induction. The 3-h images were obtained just before intravenous cell or vehicle injection. Images from sham control and hMSC are shown in rows 1 and 2, respectively, for data sets in (<Emphasis Type="Bold">a</Emphasis>) DWI and (<Emphasis Type="Bold">b</Emphasis>) T<Subscript>2</Subscript>. The infarction is observed as a high-intensity area of the ischemic side of the brain (modified from Liu et al. (<CitationRef CitationID="CR18_13">18</CitationRef>))</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_13_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Rat is placed in an animal holder/MRI probe apparatus and positioned inside the magnet. The animal’s head is held in place inside the imaging coil.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>MRI measurements are performed by using a 7-T, 18-cm-bore superconducting magnet (Oxford Magnet Technologies) interfaced to a UNITYINOVA console (Oxford Instruments, Oxford, UK; and Varian, Inc., Palo Alto, CA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Diffusion weighted images (DWI) are obtained from a 1.0-mm-thick coronal section with a 3-cm field of view, TR = 3,000 ms, TE = 37 ms and are reconstructed with a 128 × 128 image matrix, <Emphasis Type="Italic">b</Emphasis> value = 966.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>T<Subscript>2</Subscript>-weighted images (T<Subscript>2</Subscript>WI) are obtained from a 1.0-mm-thick coronal section with a 3-cm field of view, TR = 3,000 ms, TE = 30 ms and reconstructed with a 256 × 128 image matrix. Accurate positioning of the brain is performed to center the image slice 5 mm posterior to the rhinal fissure with the head of the rat held in a flat skull position.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>The ischemic lesion area is calculated from both DWI and T<Subscript>2</Subscript>WI with imaging software (Scion Image, Version Beta 4.0.2; Scion Corporation) (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_13">3</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec12_13">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>Resistance is felt and a slight curving of the suture or stretching of the ICA is observed, indicating that the blunted tip of the suture has passed the MCA origin and reached the proximal segment of the anterior cerebral artery (ACA), which has a smaller diameter. At this point, the intraluminal suture has blocked the origin of the MCA, occluding all sources of blood flow from the ICA, ACA, and posterior cerebral artery (PCA).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>During the induction of MCAO, physiological parameters (rectal temperature, blood pH, PO<Subscript>2</Subscript>, PCO<Subscript>2</Subscript>, blood pressure) should be maintained within normal ranges during surgery and transplantation procedures for all animals and should not statistically differ among the experimental groups.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>For each MRI slice, the higher intensity lesions in DWI and T<Subscript>2</Subscript>WI images where the signal intensity is 1.25 times higher than the counterpart in the contralateral brain lesion are marked as the ischemic lesion area, and infarct volume is calculated taking slice thickness (1 mm/slice) into account.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_13.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgments</Heading>
              <SimplePara>This work was supported in part by the Medical and Rehabilitation and Development Research Services of Department of ­Veterans Affairs, the National Institutes of Health (NS43432), and the National Multiple Sclerosis Society (RG2135; CA1009A10), the Paralyzed Veterans of America Research Foundation (2469), the Japanese Ministry of Education, Science, Sports and Culture (16390414), Mitsui Sumitomo Insurance Welfare Foundation, JST (Japan, Science and Technology Corporation) Innovation Plaza Hokkaido Project. The Center for Neuroscience and Regeneration Research is a collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University.</SimplePara>
            </Acknowledgments>
            <Bibliography ID="Bib1_13">
              <Heading>References</Heading>
              <Citation ID="CR1_13">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Eklof</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Siesjo</FamilyName>
                  </BibAuthorName>
                  <Year>1972</Year>
                  <ArticleTitle Language="En">The effect of bilateral carotid artery ligation upon acid-base parameters and substrate levels in the rat brain</ArticleTitle>
                  <JournalTitle>Acta Physiol Scand</JournalTitle>
                  <VolumeID>86</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>528</FirstPage>
                  <LastPage>38</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4640289</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1748-1716.1972.tb05354.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE3sXlsF2qsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eklof B, Siesjo BK (1972) The effect of bilateral carotid artery ligation upon acid-base parameters and substrate levels in the rat brain. Acta Physiol Scand;86(4):528–38.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_13">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LG</Initials>
                    <FamilyName>Salford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Plum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Brierley</FamilyName>
                  </BibAuthorName>
                  <Year>1973</Year>
                  <ArticleTitle Language="En">Graded hypoxia-oligemia in rat brain. II. Neuropathological alterations and their implications</ArticleTitle>
                  <JournalTitle>Arch Neurol</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>234</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4728182</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1001/archneur.1973.00490280046006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaE3s3ks1Sisw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Salford LG, Plum F, Brierley JB (1973) Graded hypoxia-oligemia in rat brain. II. Neuropathological alterations and their implications. Arch Neurol;29(4):234–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_13">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EZ</Initials>
                    <FamilyName>Longa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PR</Initials>
                    <FamilyName>Weinstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Carlson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Cummins</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Reversible middle cerebral artery occlusion without craniectomy in rats</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>91</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2643202</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.STR.20.1.84</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1M7gtFWhuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke;20: 84–91.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_13">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Garcia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yoshida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZG</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>142</VolumeID>
                  <FirstPage>623</FirstPage>
                  <LastPage>35</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8434652</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7msleltg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, Chen S, Chopp M (1993) Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol;142:623–35.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_13">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VG</Initials>
                    <FamilyName>Sharov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Zaloga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HN</Initials>
                    <FamilyName>Sabbah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>146</VolumeID>
                  <FirstPage>1045</FirstPage>
                  <LastPage>51</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7747798</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M3ms1KntQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Li Y, Sharov VG, Jiang N, Zaloga C, Sabbah HN, Chopp M (1995) Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol;146:1045–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_13">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CB</Initials>
                    <FamilyName>Schaffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Friedman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Nishimura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LF</Initials>
                    <FamilyName>Schroeder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Tsai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FF</Initials>
                    <FamilyName>Ebner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PD</Initials>
                    <FamilyName>Lyden</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Kleinfeld</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion</ArticleTitle>
                  <JournalTitle>PLoS Biol</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>e22</FirstPage>
                  <Occurrence Type="PID">
                    <Handle>16379497</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1371/journal.pbio.0040022</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schaffer CB, Friedman B, Nishimura N, Schroeder LF, Tsai PS, Ebner FF, Lyden PD, Kleinfeld D (2006) Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion. PLoS Biol;4(2):e22.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_13">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Jin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Xie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Childs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XO</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Logvinova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Greenberg</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>111</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>1843</FirstPage>
                  <LastPage>51</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12813020</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvV2kur4%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1172/JCI200317977</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest;111(12):1843–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_13">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Ito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Moroz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Veselits</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Hakim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Fienberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Thinakaran</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties</ArticleTitle>
                  <JournalTitle>Mol Cell Biol</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <IssueID>21</IssueID>
                  <FirstPage>9456</FirstPage>
                  <LastPage>69</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15485913</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/MCB.24.21.9456-9469.2004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXltl2isw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol;24(21):9456–69.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_13">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Treatment of neural injury with marrow stromal cells</ArticleTitle>
                  <JournalTitle>Lancet Neurol</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>92</FirstPage>
                  <LastPage>100</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12849513</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1474-4422(02)00040-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol;1(2):92–100.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_13">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Shen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Cui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kapke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Savant-Bhonsale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>2150</FirstPage>
                  <LastPage>6</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17525391</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/STROKEAHA.106.481218</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shen LH, Li Y, Chen J, Cui Y, Zhang C, Kapke A, Lu M, Savant-Bhonsale S, Chopp M (2007) One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke;38:2150–6.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_13">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Iihoshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>1007</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15064130</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brainres.2003.09.084</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXivVWlt7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD (2004) A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res;1007:1–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_13">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nomura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Harada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat</ArticleTitle>
                  <JournalTitle>Neuroscience</JournalTitle>
                  <VolumeID>136</VolumeID>
                  <FirstPage>161</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16229956</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuroscience.2005.06.062</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtFersrnO</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2005) I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience;136:161–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Honma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Iihoshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Harada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>199</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>56</FirstPage>
                  <LastPage>66</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15967439</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.expneurol.2005.05.004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD28zotFejtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD (2006) Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol;199(1):56–66.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_13">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Treatment of stroke in rat with intracarotid administration of marrow stromal cells</ArticleTitle>
                  <JournalTitle>Neurology</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>1666</FirstPage>
                  <LastPage>72</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11425931</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1212/WNL.56.12.1666</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MzmsFaqtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Li Y, Chen J, Wang L, Lu M, Chopp M (2001) Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology;56:1666–72.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_13">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kurozumi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tamiya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kawano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kobune</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hirai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model</ArticleTitle>
                  <JournalTitle>Mol Ther</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>189</FirstPage>
                  <LastPage>97</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14759803</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ymthe.2003.10.012</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXptVWrtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, et al (2004) BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther;9:189–97.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_13">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kobune</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kawano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kato</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Matsunaga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Niitsu</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy</ArticleTitle>
                  <JournalTitle>Cancer Sci</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>149</FirstPage>
                  <LastPage>56</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15771617</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1349-7006.2005.00032.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjsFWgt7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O, Houkin K, Matsunaga T, Niitsu Y (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci;96(3):149–56.</BibUnstructured>
              </Citation>
              <Citation ID="CR17_13">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mahmood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury</ArticleTitle>
                  <JournalTitle>J Neurotrauma</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>1609</FirstPage>
                  <LastPage>17</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12542861</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/089771502762300265</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mahmood A, Lu D, Wang L, Chopp M (2002) Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma;19(12):1609–17.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_13">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Harada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia</ArticleTitle>
                  <JournalTitle>Brain</JournalTitle>
                  <VolumeID>129</VolumeID>
                  <IssueID>Pt 10</IssueID>
                  <FirstPage>2734</FirstPage>
                  <LastPage>45</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16901914</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/brain/awl207</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD28rntVKmsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD (2006) Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain;129(Pt 10):2734–45.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_13">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Horita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Harada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>1495</FirstPage>
                  <LastPage>504</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16998918</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.21056</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xht1eisrrN</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2006) Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res;84(7):1495–504.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_13">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Ukai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Harada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Houkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hamada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Mesenchymal stem cells derived from peripheral blood protects against ischemia</ArticleTitle>
                  <JournalTitle>J Neurotrauma</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>508</FirstPage>
                  <LastPage>20</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17402856</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/neu.2006.0161</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ukai R, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2007) Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma;24(3):508–20.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>